Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Flament

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|October 28, 1999
Influence of the technological parameters of ultrasonic nebulisation on the nebulisation quality of alpha1 protease inhibitor (alpha1PI)M P Flament, P Leterme, A Gayot
Drug Development and Industrial Pharmacy|November 6, 2001
Study of the technological parameters of ultrasonic nebulizationM P Flament, P Leterme, A Gayot
International Journal of Pharmaceutics|April 17, 1999
Influence of formulation on jet nebulisation quality of alpha 1 protease inhibitorM P Flament, P Leterme, T Burnouf, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 27, 2011
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulationsV N P Le, E Robins, M P Flament
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 22, 2010
Air permeability of powder: a potential tool for Dry Powder Inhaler formulation developmentV N P Le, E Robins, M P Flament
International Journal of Pharmaceutics|November 23, 2006
Influence of carrier on the performance of dry powder inhalersG Saint-Lorant, P Leterme, A Gayot, et al.
Drug Development and Industrial Pharmacy|June 29, 2000
Formulation of activated charcoal for per os administration to addicted subjectsM P Flament, R M'bisi, P Leterme, et al.
International Journal of Pharmaceutics|January 18, 2005
Influence of the morphogranulometry and hydrophobicity of talc on its antisticking power in the production of tabletsP Leterme, A Gayot, G Finet, et al.
Drug Development and Industrial Pharmacy|March 6, 2004
Development of 400 microm pellets by extrusion-spheronization: application with Gelucire 50/02 to produce a "sprinkle" formM P Flament, G Dupont, P Leterme, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 9, 2003
Relation between structural characteristics of talc and its properties as an antisticking agent in the production of tabletsM Bizi, M P Flament, P Leterme, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|October 28, 1999
Influence of the technological parameters of ultrasonic nebulisation on the nebulisation quality of alpha1 protease inhibitor (alpha1PI)M P Flament, P Leterme, A Gayot
Drug Development and Industrial Pharmacy|November 6, 2001
Study of the technological parameters of ultrasonic nebulizationM P Flament, P Leterme, A Gayot
International Journal of Pharmaceutics|April 17, 1999
Influence of formulation on jet nebulisation quality of alpha 1 protease inhibitorM P Flament, P Leterme, T Burnouf, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 27, 2011
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulationsV N P Le, E Robins, M P Flament
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 22, 2010
Air permeability of powder: a potential tool for Dry Powder Inhaler formulation developmentV N P Le, E Robins, M P Flament
International Journal of Pharmaceutics|November 23, 2006
Influence of carrier on the performance of dry powder inhalersG Saint-Lorant, P Leterme, A Gayot, et al.
Drug Development and Industrial Pharmacy|June 29, 2000
Formulation of activated charcoal for per os administration to addicted subjectsM P Flament, R M'bisi, P Leterme, et al.
International Journal of Pharmaceutics|January 18, 2005
Influence of the morphogranulometry and hydrophobicity of talc on its antisticking power in the production of tabletsP Leterme, A Gayot, G Finet, et al.
Drug Development and Industrial Pharmacy|March 6, 2004
Development of 400 microm pellets by extrusion-spheronization: application with Gelucire 50/02 to produce a "sprinkle" formM P Flament, G Dupont, P Leterme, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 9, 2003
Relation between structural characteristics of talc and its properties as an antisticking agent in the production of tabletsM Bizi, M P Flament, P Leterme, et al.
Pageof 3